Title:
1型および2型糖尿病を処置するためのSGLT1およびSGLT2阻害作用を有する3-アミノイミダゾ[1,2-a]ピリジン誘導体
Document Type and Number:
Japanese Patent JP5307718
Kind Code:
B2
Abstract:
Novel compounds of the formula (I), in which W, T, R1, R2, R3, R4, R5 and R6 have the meanings indicated in Patent Claim (1), are suitable as antidiabetics.
Inventors:
Klein, Marx
Gerikke, rolf
Bayer, Norbert
Cezanne, Beatram
Zakura Kydis, Christos
Medellsky, Werner
Gerikke, rolf
Bayer, Norbert
Cezanne, Beatram
Zakura Kydis, Christos
Medellsky, Werner
Application Number:
JP2009532697A
Publication Date:
October 02, 2013
Filing Date:
September 27, 2007
Export Citation:
Assignee:
Merck Patent Gesellschaft mit beschraenkter Haftung
International Classes:
C07D471/04; A61K31/437; A61K31/444; A61K31/506; A61P3/10
Domestic Patent References:
| JP2004510820A |
Foreign References:
| WO2006094235A1 | ||||
| WO2005085267A1 |
Attorney, Agent or Firm:
Kiyoji Kuzuwa
Previous Patent: 自発光型の発光装置
Next Patent: MAGNETIC DOMAIN OBSERVATION AND MAGNETIZATION MEASURING INSTRUMENT
Next Patent: MAGNETIC DOMAIN OBSERVATION AND MAGNETIZATION MEASURING INSTRUMENT